The pharma group is paying CHF 450 million (around $507 million) for the privately-held biotech, which was formed to develop a platform that uses live bacteria to deliver therapeutic, immune ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Using advanced DNA sequence analysis, a research team has discovered that tiny organisms in Brooklyn's highly contaminated Gowanus Canal have developed a comprehensive collection of pollution-fighting ...

Bacteria naturally present in the human intestine (known as the gut microbiota) can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

As per Vantage Market Research, the Global Pharmaceutical Sterility Testing Market has been significantly growing over the ...

and only the third oncolytic virus therapy to be made available to patients worldwide, after Shanghai Sunway Biotech's Oncorine for nasopharyngeal carcinoma in 2005 and Amgen's Imlygic (talimogene ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...